Elevance Health
1,470 hedge funds and large institutions have $57B invested in Elevance Health in 2026 Q1 according to their latest regulatory filings, with 144 funds opening new positions, 486 increasing their positions, 646 reducing their positions, and 208 closing their positions.
89% more call options, than puts
Call options by funds: $550M | Put options by funds: $291M
2.69% less ownership
Funds ownership: 91% → 88.31% (-2.7%)
5% less funds holding
Funds holding: 1,555 → 1,470 (-85)
20% less capital invested
Capital invested by funds: $71B → $57B (-$13.9B)
25% less repeat investments, than reductions
Existing positions increased: 486 | Existing positions reduced: 646
31% less first-time investments, than exits
New positions opened: 144 | Existing positions closed: 208
35% less funds holding in top 10
Funds holding in top 10: 31 → 20 (-11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Amundi
Paris,
France
|
+$525M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$300M |
| 3 |
SG Americas Securities
New York
|
+$184M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$168M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$163M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$887M |
| 2 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$349M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$265M |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$195M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$176M |
ELV Hedge Fund Activity: Q1 2026 in Review
1,470 of the 8,184 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q1 2026, worth a combined $57B — down 20% from $71B a quarter earlier.
Sellers outnumbered buyers: 208 funds closed out of ELV and 144 opened new positions — a net loss of 64 holders — while 646 trimmed existing stakes and 486 added.
The largest buyer was Amundi, adding an estimated $525M. The largest seller was T. Rowe Price Associates, cutting an estimated $887M.
- 1,470 institutional investors held Elevance Health (ELV) as of Q1 2026, down from 1,555 in Q4 2025.
- Funds reported $57B of Elevance Health stock for Q1 2026, down 20% quarter-over-quarter.
- 144 funds opened new Elevance Health positions in Q1 2026 and 208 closed out, a net change of -64 holders.
- The largest Elevance Health buyer in Q1 2026 was Amundi, an estimated $525M added.
- The largest Elevance Health seller in Q1 2026 was T. Rowe Price Associates, an estimated $887M sold.
Based on aggregated 13F filings for Q1 2026.